An open‐label, 4‐week, prospective clinical study evaluating the efficacy and safety of a novel targeted skin care line addressing five common skin conditions. (28th July 2022)

• Record Type: Journal Article
• Authors: Duschek, Nikolaus; Cajkovsky, Mia; Prinz, Valentina; Müller, Daniel; Hundsamer, Andrea; Baierl, Andreas; Möllhoff, Nicholas; Sulovsky, Monika; Frank, Konstantin
• Is Part Of: Journal of cosmetic dermatology. Volume 21:Number 11(2022)
• Page Start: 5760
• Page End: 5768
• Publication Date: 2022-07-28
• Subjects: clinical trial -- cosmeceuticals -- irritated skin -- skin condition -- targeted skin care; Skin -- Diseases -- Treatment -- Periodicals; Lasers in surgery -- Periodicals; Skin -- Pathophysiology -- Periodicals; Surgery, Plastic -- Periodicals; 616.5
• DOI: 10.1111/jocd.15223
• Languages: English
• ISSNs: 1473-2130

Abstract

Abstract: Background: Common skin conditions, such as irritated, dry, aging, and oily skin or dark eye circles with periorbital edema, usually do not require pharmaceutical therapy in form of dermatological drugs. They can, however, still affect the quality of life significantly. With the advent of newer cosmetics, a more targeted treatment of these dermatological conditions has become available to the public. There are few clinical studies investigating the efficacy and safety of cosmetics, leaving consumers exposed to potentially false claims of the cosmetic industry. This study aims to assess the efficacy and safety of a novel skin care series addressing the aforementioned five common skin conditions. Methods: This open‐label, single‐center, 4‐week, prospective clinical study evaluated the efficacy and safety of five novel skin care formulations, each targeting one of five common skin issues in 176 study subjects. The primary endpoint parameters for the change in irritated skin, dark and puffy eyes, dry skin, aging skin, and oily skin were assessed through validated questionnaires, scales, and biomedical devices. Results: After 4 weeks of topical application of each formulation of a new targeted skin care, a significant improvement in all primary endpoints was detected. No undesirable effects occurred during this study. Conclusion: This study showed a significant improvement in five common dermatological conditions with a novel targeted skin care series. Moreover, this study leads the way for an overdue critical assessment and certification of cosmetic product claims.